Skip to main content
Drugmakers to pay $1.54M to settle pay-for-delay lawsuit
8/21/2019

Amneal, Sun Pharma, Upsher-Smith and Wockhardt agreed to pay a combined $1.54 million to settle allegations that they illegally prevented market entry of a generic version of the Alzheimer's disease drug Namenda.

Full Story: